CORONAVIRUS CLINICAL RESEARCH SUBJECTS IN NIGERIA: AN ETHICAL FRAMEWORK
Coronavirus made its way into our world in 2019. As the virus began to spread,the World Health Organization, WHO judged it to be a pandemic. Pandemic because it had spread to over 200 countries in a short space of time, leaving in its wake scores of dead persons. A virus is deadly by nature. The only option is to develop a vaccine that will help stem the spread of the deadly virus. Development of vaccine takes a whole lot of time. Besides, efficacy of the vaccine depends on a robust clinical trial enabling the investigator to have a wide range of volunteers as well as patients to participate in the clinical trial. Two things are of paramount value: keeping proper ethical protocols and good data. Good record keeping will be helpful in tracking the progress made in the development of the vaccine, and also noting the reactions of people during the clinical trials. Abuse of the research participants should be minimized as much as possible. There is need for the Institutional Review Board (IRB) to ensure that the ethical principlesare followed; and that research participants-patients and volunteers-are properly informed and so give their informed consent.